WeVote
Log In

Bill

Bill

SB 641

Office-based buprenorphine treatment; Board of Medicine to amend regulations.

2026 Regular Session Introduced by Luther Cifers and 12 co-sponsors

Virginia directs its Board of Medicine to establish regulations allowing physicians to provide buprenorphine treatment for opioid addiction in office settings, expanding medication access beyond specialized clinics.

Reported from Education and Health (14-Y 0-N)
0
WeVote Research Nonpartisan
Bill Summary · SB 641

Legislative bill overview

SB 641 directs Virginia's Board of Medicine to amend its regulations to establish or expand standards for office-based buprenorphine treatment by healthcare providers. Buprenorphine is a medication used to treat opioid use disorder, typically dispensed in controlled clinical settings. This bill seeks to create a clearer regulatory framework for physicians and other medical professionals to provide this treatment in their offices rather than exclusively in specialized clinics.

Why is this important

Opioid addiction remains a significant public health crisis, and expanding access to medication-assisted treatment (MAT) can reduce overdose deaths and improve recovery outcomes. Office-based buprenorphine treatment could increase accessibility for rural patients, reduce stigma, and integrate addiction treatment into primary care. However, regulatory standards are critical to ensure patient safety, prevent diversion of controlled substances, and maintain prescriber accountability.

Potential points of contention

  • Provider qualifications and training requirements: Disagreement over what level of training, certification, or experience physicians need before prescribing buprenorphine in office settings, balancing accessibility against safety concerns
  • Patient monitoring and safeguards: Debate about appropriate frequency of follow-up visits, drug screening protocols, and psychosocial support requirements to prevent medication misuse while keeping treatment practical
  • Oversight and enforcement mechanisms: Questions about how the Board of Medicine will monitor office-based prescribers, handle complaints, and prevent over-prescription or diversion without creating excessive regulatory burden

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.